Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA's Post-Shutdown ANDA Bolus Could Be Massive

Jan 25 2019

• By Derrick Gingery

Generics

Related Content

There's The Bolus! ANDA Sponsors Race To Avoid User Fee Spike

Oct 10 2017

Generic Drug Puzzle: Why Did ANDA Submissions Spike Again?

Apr 11 2017

ANDA Avalanche: How Will FDA Deal With The 600 Received This Month?

Jun 30 2014

US FDA Shuttering More Operations As User Fee Money Dwindles

Jan 24 2019

US FDA Generic Drug Office Director Uhl Announces Retirement

Jul 18 2018

Shutdown Week Four: FDA Maintains Pre-Shutdown Output Pace In Some Cases

Jan 14 2019

US Federal Courts Can Operate Until Jan. 25; Patent Office Faces Eminent Closure Under Shutdown

Jan 17 2019

ANDA Stress Test: End-Of-Year Submission Bolus Pressures US FDA Review System

Jan 09 2017

Additional Topics

United States Generic Drugs FDA Regulation Review Pathway BioPharmaceutical

More from Generics

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window